Evidence map›Paper›PMID 38205253›Full record

ArticleiScience2024

The sound of silent RNA in tuberculosis and the lncRNA role on infection.

Eduardo Fukutani Rocha, Caian Leal Vinhaes, Mariana Araújo-Pereira, Tiago Feitosa Mota, Akshay N Gupte, Nathella Pavan Kumar, Maria Belen Arriaga, Timothy R Sterling, Subash Babu, Sanjay Gaikwad and 11 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. LncRNA-CFTBS enhancesVirulence · 2025
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 3 countries.

Eduardo Fukutani RochaCentro de Integração de Dados e Conhecimentos para Saúde, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Caian Leal VinhaesLaboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Mariana Araújo-PereiraLaboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Tiago Feitosa MotaCentro de Integração de Dados e Conhecimentos para Saúde, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Akshay N GupteBoston University School of Public Health, Boston, MA USA.
Nathella Pavan KumarICMR-National Institute for Research in Tuberculosis, Chennai, India.
Maria Belen ArriagaLaboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Timothy R SterlingDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN USA.
Subash BabuNational Institutes of Health- NIRT - International Center for Excellence in Research, Chennai, India.
Sanjay GaikwadDepartment of Pulmonary Medicine, Byramjee-Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, India.
Rajesh KaryakarteDepartment of Microbiology, Byramjee-Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, India.
Vidya MaveByramjee-Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
Vandana KulkarniByramjee-Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
Mandar ParadkarByramjee-Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
Vijay ViswanathanProf. M. Viswanathan Diabetes Research Centre, Chennai, India.
Hardy KornfeldDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA USA.
Amita GuptaByramjee-Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
Bruno Bezerril AndradeLaboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Artur Trancoso Lopo de QueirozCentro de Integração de Dados e Conhecimentos para Saúde, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
RePORT Brazil
RePORT India Consortia
Fundação Oswaldo Cruz · BRGovernment Medical College · INB. J. Medical College & Sassoon Hospital · INBoston University · USIndia Diabetes Research Foundation · INInternational Centers for Excellence in Research · INJohns Hopkins University · USNational Institute of Research in Tuberculosis · INUniversity of Massachusetts Chan Medical School · US

Funding

CCASAnet: Caribbean, Central and South America NetworkU01AI069923 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Pedro Enrique Cahn, Jessica L Castilho · 2006 to 2026
$41.6M
India International Center for Excellence in ResearchZIAAI001065 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI NUTMAN, THOMAS · 2009 to 2025
$19.0M
Regional Prospective Observational Research in Tuberculosis (RePORT) – Brazil NetworkU01AI172064 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BRUNO DE BEZERRIL ANDRADE, TIMOTHY R STERLING · 2023 to 2026
$4.0M
Predictors of treatment toxicity, failure, and relapse in HIV-related tuberculosisR01AI120790 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ROLLA, VALERIA CAVALCANTI, STERLING, TIMOTHY R · 2016 to 2019
$2.6M
NIAID NIH HHS R01 AI120790NIAID NIH HHS U01 AI069923NIAID NIH HHS U01 AI172064
6 · The paper itself

Abstract

Tuberculosis (TB) is one of the leading causes of death worldwide, and Diabetes Mellitus is one of the major comorbidities (TB/DM) associated with the disease. A total of 103 differentially expressed ncRNAs have been identified in the TB and TB/DM comparisons. A machine learning algorithm was employed to identify the most informative lncRNAs: ADM-DT, LINC02009, LINC02471, SOX2-OT, and GK-AS1. These lncRNAs presented substantial accuracy in classifying TB from HC (AUCs >0.85) and TB/DM from HC (AUCs >0.90) in the other three countries. Genes with significant correlations with the five lncRNAs enriched common pathways in Brazil and India for both TB and TB/DM. This suggests that lncRNAs play an important role in the regulation of genes related to the TB immune response.

Indexed as

Health sciencesInfection control in health technology

Identifiers

PMID38205253
PMCPMC10777062
OpenAlexW4389486064

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.